The Ibr‐7 derivative of ibrutinib exhibits enhanced cytotoxicity against non‐small cell lung cancer cells via targeting of mTORC1/S6 signaling

Ibrutinib is a small molecule drug that targets Bruton's tyrosine kinase in B‐cell malignancies and is highly efficient at killing mantle cell lymphoma and chronic lymphocytic leukemia. However, the anti‐cancer activity of ibrutinib against solid tumors, such as non‐small cell lung cancer (NSCL...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bo Zhang, Linling Wang, Qi Zhang, Youyou Yan, Hong Jiang, Runlei Hu, Xinglu Zhou, Xingguo Liu, Jianguo Feng, Nengming Lin
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley 2019-04-01
Colecção:Molecular Oncology
Assuntos:
ABT‐199
Ibr‐7
ibrutinib
mTORC1, S6
non‐small cell lung cancer
Acesso em linha:https://doi.org/10.1002/1878-0261.12454
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados